Maas Biolab, Inc.

Maas Biolab is a neuropharmaceutical company developing a treatment- the use of cyclosporins as neuro-protectants- for chronic neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer's, Parkinson's and Huntington's.
NeuroPharma AB, a Maas Biolab Swedish partner, is developing cyclosporin for treatment of the acute neurological indications of stroke, spinal trauma, and traumatic brain injury.

Maas Biolab’s patent and related intellectual property rights consist of "new use" patents, formulation patents and production patents for cyclosporins as neuroprotective agents issued or pending in the USA, Canada, Australia, New Zealand, and ARIPO (Africa), Europe (EPO), Japan, China, Russia and Mexico.

Members of the cyclosporin family display powerful neuroprotective properties in neuro-degeneration by preventing or reducing neuron cell death, by blocking critical enzymes and free radicals and protecting the mitochondria. Pre-clinical studies show cyclosporin-A to be the most powerful known neuroprotectant in ALS with promise also in Alzheimer's, Huntington's, and Parkinson's diseases.

Contact Details: 1155 University Blvd. SE Albuquerque New Mexico 87106 United States of America Tel: 1 (505) 843-4230 Fax: 1 (505) 246-2891 Email: michael@maasbiolab.com WWW: www.maasbiolab.com/

Loading...

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 252 times since April 2007, the link to the organisation's website has been followed 57 times

Recent Search Terms used to find this page: maas biolab 2009 | .

Search for more companies in Albuquerque

Search for more companies in New Mexico

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Maas Biolab, Inc.